Anti Angiogenesis Drug Discovery And Development

Author : Atta-ur- Rahman
Publisher : Bentham Science Publishers
ISBN 13 : 1608051625
Total Pages : 197 pages
Book Rating : 4.25/5 ( download)

DOWNLOAD NOW!

Download or read book Anti-angiogenesis Drug Discovery and Development written by Atta-ur- Rahman and published by Bentham Science Publishers. This book was released on 2011 with total page 197 pages. Available in PDF, EPUB and Kindle. Book excerpt: "The inhibition of angiogenesis is an effective mechanism of slowing down tumor growth and malignancies. The process of induction or pro-angiogenesis is highly desirable for the treatment of cardiovascular diseases, wound healing disorders, etc. Efforts to"

Author : Atta-ur-Rahman
Publisher : Bentham Science Publishers
ISBN 13 : 9811432864
Total Pages : 212 pages
Book Rating : 4.66/5 ( download)

DOWNLOAD NOW!

Download or read book Anti-Angiogenesis Drug Discovery and Development: Volume 5 written by Atta-ur-Rahman and published by Bentham Science Publishers. This book was released on 2020-10-05 with total page 212 pages. Available in PDF, EPUB and Kindle. Book excerpt: The inhibition of angiogenesis is an effective mechanism of slowing down tumor growth and malignancies. The process of induction or pro-angiogenesis is highly desirable for the treatment of cardiovascular diseases, and wound healing disorders. Efforts to understand the molecular basis, both for inhibition and induction, have yielded fascinating results. Anti-angiogenesis Drug Discovery and Development provides an excellent compilation of well-written reviews on various aspects of the anti-angiogenesis process. These reviews have been contributed by leading practitioners in drug discovery science and highlight the major developments in this exciting field in the last two decades. The feast of these reader-friendly reviews on topics of great scientific importance – many of which are considered significant medical breakthroughs, makes this series excellent reading both for the novice as well as for expert medicinal chemists and clinicians. The fifth volume brings together reviews on the following topics: - Targeted therapy for tumor vasculature - Anti-angiogenic therapy for breast and prostate cancers (including information updates on clinical trials) - Microbe-based and other novel antiangiogenesis therapies such as chromene-based agents

Author : Atta-ur Rahman
Publisher : Elsevier
ISBN 13 : 0128039647
Total Pages : 327 pages
Book Rating : 4.49/5 ( download)

DOWNLOAD NOW!

Download or read book Anti-Angiogenesis Drug Discovery and Development written by Atta-ur Rahman and published by Elsevier. This book was released on 2015-06-16 with total page 327 pages. Available in PDF, EPUB and Kindle. Book excerpt: The inhibition of angiogenesis is an effective mechanism of slowing down tumor growth and malignancies. The process of induction or pro-angiogenesis is highly desirable for the treatment of cardiovascular diseases, wound healing disorders, and more. Efforts to understand the molecular basis, both for inhibition and induction, have yielded fascinating results. Originally published by Bentham and now distributed by Elsevier, Anti-Angiogenesis Drug Discovery and Development, Volume 2 is an compilation of well-written reviews on various aspects of the anti-angiogenesis process. These reviews have been contributed by leading practitioners in drug discovery science and highlight the major developments in this exciting field in the last two decades. These reader-friendly chapters cover topics of great scientific importance, many of which are considered significant medical breakthroughs, making this book excellent reading both for the novice as well as for expert medicinal chemists and clinicians. Edited and written by leading experts in angiogenesis drug development Reviews recent advances in the field, such as coverage of anti-angiogenetic drugs in ovarian cancer Reports current strategies and future outlook for anti-angiogenic therapy and cardiovascular diseases

Author : Atta-ur-Rahman
Publisher : Bentham Science Publishers
ISBN 13 : 1681083981
Total Pages : 242 pages
Book Rating : 4.88/5 ( download)

DOWNLOAD NOW!

Download or read book Anti-Angiogenesis Drug Discovery and Development: Volume 4 written by Atta-ur-Rahman and published by Bentham Science Publishers. This book was released on 2019-06-10 with total page 242 pages. Available in PDF, EPUB and Kindle. Book excerpt: "The inhibition of angiogenesis is an effective mechanism of slowing down tumor growth and malignancies. The process of induction or pro-angiogenesis is highly desirable for the treatment of cardiovascular diseases, wound healing disorders, etc. Efforts to understand the molecular basis, both for inhibition and induction, have yielded fascinating results.Anti-angiogenesis Drug Discovery and Development provides an excellent compilation of well-written reviews on various aspects of the anti-angiogenesis process. These reviews have been contributed by leading practitioners in drug discovery science and highlight the major developments in this exciting field in the last two decades. The feast of these reader-friendly reviews on topics of great scientific importance – many of which are considered significant medical breakthroughs, makes this series excellent reading both for the novice as well as for expert medicinal chemists and clinicians.This volume brings together 5 reviews on the following topics:- Retinal angiogenesis- Effects of brief daily EMF therapy on tumor growths- Evolution of the role of angiogenesis in cancer treatments over six decades- Anti-angiogenesis drugs- Anti-angiogenesis therapy for multiple sclerosis- Update on the link between angiogenesis and portal hypertension"

Author : Atta-ur Rahman
Publisher :
ISBN 13 : 9781608058679
Total Pages : pages
Book Rating : 4.70/5 ( download)

DOWNLOAD NOW!

Download or read book Anti-Angiogenesis Drug Discovery and Development written by Atta-ur Rahman and published by . This book was released on 2014-01-01 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt: The inhibition of angiogenesis is an effective mechanism of slowing down tumor growth and malignancies. The process of induction or pro-angiogenesis is highly desirable for the treatment of cardiovascular diseases, wound healing disorders, etc. Efforts to understand the molecular basis, both for inhibition and induction, have yielded fascinating results. Anti-angiogenesis Drug Discovery and Development provides an excellent compilation of well-written reviews on various aspects of the anti-angiogenesis process. These reviews have been contributed by leading practitioners in drug discovery science and highlight the major developments in this exciting field in the last two decades. The feast of these reader-friendly reviews on topics of great scientific importance - many of which are considered significant medical breakthroughs, makes this book excellent reading both for the novice as well as for expert medicinal chemists and clinicians.

Author :
Publisher :
ISBN 13 :
Total Pages : pages
Book Rating : 4.12/5 ( download)

DOWNLOAD NOW!

Download or read book Anti-Angiogenesis Drug Discovery and Development: Volume 2 written by and published by . This book was released on with total page pages. Available in PDF, EPUB and Kindle. Book excerpt:

Author : Shaker Mousa
Publisher : Academic Press
ISBN 13 : 0128026731
Total Pages : 210 pages
Book Rating : 4.31/5 ( download)

DOWNLOAD NOW!

Download or read book Anti-Angiogenesis Strategies in Cancer Therapies written by Shaker Mousa and published by Academic Press. This book was released on 2016-11-28 with total page 210 pages. Available in PDF, EPUB and Kindle. Book excerpt: Anti-angiogenesis Strategies in Cancer Therapeutics provides a detailed look at the current status and future directions in the discovery and development of novel anti-angiogenesis strategies in oncology. This book highlights the different mechanisms involved in the modulation of angiogenesis, including inflammation, thrombosis, and microRNA, and shows how nanotechnology can further enhance the potential of existing and new anti-angiogenesis approaches. Written for industry scientists, researchers, oncologists, hematologists, and professors and students in the field, this comprehensive book covers all aspects of anti-angiogenesis strategies and their differences. Covers important preclinical models and clinical trials in the discovery and development of novel anti-angiogenesis agents Reviews FDA-approved anti-angiogenesis agents Illustrates the value of nanotechnology in improving the utility of anti-angiogenesis agents Offers insight into the development of novel anti-angiogenesis agents and future direction in this area

Author : Elizabeth Garrett-Mayer
Publisher : Springer Science & Business Media
ISBN 13 : 1441973583
Total Pages : 673 pages
Book Rating : 4.80/5 ( download)

DOWNLOAD NOW!

Download or read book Principles of Anticancer Drug Development written by Elizabeth Garrett-Mayer and published by Springer Science & Business Media. This book was released on 2010-12-29 with total page 673 pages. Available in PDF, EPUB and Kindle. Book excerpt: A practical guide to the design, conduction, analysis and reporting of clinical trials with anticancer drugs.

Author : Beverly A. Teicher
Publisher : Springer Science & Business Media
ISBN 13 : 1592594530
Total Pages : 445 pages
Book Rating : 4.35/5 ( download)

DOWNLOAD NOW!

Download or read book Antiangiogenic Agents in Cancer Therapy written by Beverly A. Teicher and published by Springer Science & Business Media. This book was released on 1998-12-28 with total page 445 pages. Available in PDF, EPUB and Kindle. Book excerpt: Beverly Teicher and a panel of distinguished investigators survey the state-of-the-art of antiangiogenesis research from the lab bench to clinical trials. Timely and authoritative, the contributors summarize our current understanding of tumor growth and its dependence on vascular development, as well as the present status of antiangiogenic agents in preclinical and clinical development. In addition, the book also examines what is known about the mechanisms by which these therapeutic agents interfere with tumor vasculature and grapples with the problem of establishing criteria by which to assess their clinical efficacy. Antiangiogenic Agents in Cancer Therapy offers a unique cutting-edge compendium of antiangiogenic research, taking stock of what has been accomplished , where the experimental therapeutics of antiangiogenic agents is going, and the continuing evolution of their role in cancer treatment and novel drug development.

Author : George C. Prendergast
Publisher : John Wiley & Sons
ISBN 13 : 9780471432029
Total Pages : 370 pages
Book Rating : 4.24/5 ( download)

DOWNLOAD NOW!

Download or read book Molecular Cancer Therapeutics written by George C. Prendergast and published by John Wiley & Sons. This book was released on 2004-04-02 with total page 370 pages. Available in PDF, EPUB and Kindle. Book excerpt: Molecular Cancer Therapeutics covers state-of-the-art strategies to identify and develop cancer drug target molecules and lead inhibitors for clinical testing. It provides a thorough treatment of drug target discovery, validation, and development. The introductory chapters provide an overview of pathways to discovery and development of molecular cancer therapeutics. Subsequent chapters progress from initial stages of drug target discovery to drug discovery, development, and testing in preclinical and clinical models. Topics include drug lead screening, drug-to-lead development, proof-of-concept studies, medicinal chemistry issues, intellectual property concerns, and clinical development. This invaluable reference promotes understanding of steps involved in developing drug leads for industrial partnering and development. It provides an overview of the strategies for discovery and validation of drug target molecules, and discusses cell- and molecule-based drug screening strategies, as well as mouse models for cancer. Coverage also includes how to refine drug leads for suitability in clinical testing, the special issues of clinical testing of molecular-targeted drugs, and intellectual property concerns.